-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Catalyst Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
- Catalyst Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $55.9M, a 60.5% increase year-over-year.
- Catalyst Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $164M, a 130% increase year-over-year.
- Catalyst Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $164M, a 130% increase from 2023.
- Catalyst Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $71.4M, a 14% decline from 2022.
- Catalyst Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $83.1M, a 110% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)